Background and objectivesTo simulate the cost-effectiveness of Mesenchymal Stromal Cell (MSC) therapy compared to sodium/glucose co-transporter 2 inhibitors (SGLT2i) or usual care (UC) in treating patients with Diabetic Kidney Disease (DKD). Design. setting. participants. https://www.ealisboa.com/flash-sale-Santa-Cruz-Surfboard-Recycled-Cotton-great-price/